好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Treatment of MS Patients with Selective PDE-4 Inhibitor Rolipram Inhibits Th1/Th17 T Cell Responses, but Fails To Inhibit Brain Inflammatory Activity
MS and Related Diseases
(-)
001
Authors/Disclosures
Bibiana Bielekova, MD, FAAN (Neuroimmunological Diseases Section/NIAID/NIH) Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
No disclosure on file
Nancy D. Richert, MD, PhD (Research Imaging LLC) No disclosure on file
Jayne H. Ward, DO, FAAN (MSU Neurology) No disclosure on file
No disclosure on file
Joan M. Ohayon (National Institutes of Health) Joan M. Ohayon has nothing to disclose.
Henry F. McFarland, MD (Clinical Neuroscience Consulting) Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
Roland M. Martin, MD (ICREA Unitat De Neuroimmunologia Clinica Esquela D' Infermeria) No disclosure on file